D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 9.69% |
| 2 | Consumer Discretionary | 9.53% |
| 3 | Technology | 9.28% |
| 4 | Healthcare | 8.29% |
| 5 | Financials | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRO
2651
CALL
DELISTED
Marathon Oil Corporation
MRO
| $862K | ﹤0.01% |
33,000
-117,600
| -78% | -$3.19M |
|
2652
British American Tobacco
BTI
$134B
| $859K | ﹤0.01% |
16,562
+7,810
| +89% | +$433K |
|
2653
CALL
Canadian National Railway
CNI
$78.3B
| $856K | ﹤0.01% |
12,800
-10,000
| -44% | -$680K |
|
2654
Inovio Pharmaceuticals
INO
$84.7M
| $856K | ﹤0.01% |
8,747
-4,236
| -33% | -$410K |
|
2655
Universal Technical Institute
UTI
$2.15B
| $855K | ﹤0.01% |
89,077
-1,980
| -2% | -$18.4K |
|
2656
Plug Power
PLUG
$2.73B
| $854K | ﹤0.01% |
+329,570
| New | +$955K |
|
|
RTN
2657
DELISTED
Raytheon Company
RTN
| $852K | ﹤0.01% |
7,799
-143,947
| -95% | -$15.5M |
|
|
P
2658
PUT
DELISTED
Pandora Media Inc
P
| $851K | ﹤0.01% |
52,500
-238,700
| -82% | -$3.82M |
|
|
ROSE
2659
CALL
DELISTED
ROSETTA RESOURCES INC
ROSE
| $851K | ﹤0.01% |
+50,000
| New | +$957K |
|
2660
AutoZone
AZO
$50.9B
| $848K | ﹤0.01% |
1,244
-3,619
| -74% | -$2.27M |
|
2661
PUT
Coeur Mining
CDE
$15.4B
| $848K | ﹤0.01% |
180,000
-50,000
| -22% | -$291K |
|
|
TC
2662
DELISTED
Thompson Creek Metals Company Inc. Ordinary Shares (Canada)
TC
| $848K | ﹤0.01% |
642,601
-58,458
| -8% | -$82.1K |
|
|
PNNT
2663
Pennant Park Investment Corp
PNNT
$221M
| $847K | ﹤0.01% |
+93,579
| New | +$860K |
|
2664
Associated Banc-Corp
ASB
$5.86B
| $846K | ﹤0.01% |
45,482
-145,127
| -76% | -$2.63M |
|
2665
Renasant Corp
RNST
$4.05B
| $846K | ﹤0.01% |
28,147
+5,612
| +25% | +$158K |
|
|
TW
2666
CALL
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
| $846K | ﹤0.01% |
+6,400
| New | +$802K |
|
2667
PUT
Workday
WDAY
$39.4B
| $844K | ﹤0.01% |
10,000
-40,000
| -80% | -$3.38M |
|
|
CCXI
2668
DELISTED
ChemoCentryx, Inc.
CCXI
| $844K | ﹤0.01% |
111,770
+10,612
| +10% | +$82.9K |
|
|
JRN
2669
DELISTED
JOURNAL COMMUNICATIONS INC CL-A
JRN
| $844K | ﹤0.01% |
56,929
-53,461
| -48% | -$624K |
|
2670
UGI
UGI
$7.92B
| $843K | ﹤0.01% |
+25,867
| New | +$907K |
|
|
GHDX
2671
DELISTED
Genomic Health, Inc.
GHDX
| $842K | ﹤0.01% |
27,573
+15,489
| +128% | +$492K |
|
|
PERY
2672
DELISTED
Perry Ellis International Inc
PERY
| $842K | ﹤0.01% |
36,343
+13,724
| +61% | +$328K |
|
2673
Carriage Services
CSV
$648M
| $841K | ﹤0.01% |
35,222
+2,982
| +9% | +$67.5K |
|
2674
Medtronic
MDT
$111B
| $841K | ﹤0.01% |
10,785
+453
| +4% | +$34.3K |
|
2675
CALL
Ionis Pharmaceuticals
IONS
$9.14B
| $840K | ﹤0.01% |
13,200
-28,600
| -68% | -$1.94M |
|
Similar funds
D.E. Shaw & Co's Q1 2015 Portfolio in Review
As of Q1 2015, D.E. Shaw & Co held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 9.7% of assets, up from 8% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, D.E. Shaw & Co opened a new position in SPDR Gold Trust worth $231M.
- D.E. Shaw & Co's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- D.E. Shaw & Co added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- D.E. Shaw & Co's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- D.E. Shaw & Co fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- D.E. Shaw & Co opened 448 new positions and closed 828 in Q1 2015.
- D.E. Shaw & Co's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.